Ensysce Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 490.5%.

Top 18 shareholders own 3.7% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.61%	Robert Gower	121,890	US$68.4k	0%	no data
0.41%	Hui-Chung Chang	31,231	US$17.5k	0%	no data
0.37%	Heights Capital Management, Inc.	28,073	US$15.7k	0%	0.01%
0.26%	Andrew Benton	20,025	US$11.2k	0%	no data
0.26%	HG Vora Capital Management, LLC	19,812	US$11.1k	0%	no data
0.24%	The Vanguard Group, Inc.	18,175	US$10.2k	17.9%	no data
0.21%	Geode Capital Management, LLC	16,281	US$9.1k	-0.91%	no data
0.14%	Renaissance Technologies LLC	10,957	US$6.1k	0%	no data
0.083%	Tower Research Capital LLC	6,307	US$3.5k	60.7%	no data
0.048%	Hydra Lac, Llc	3,616	US$2.0k	0%	no data
0.021%	D. Kirkpatrick	1,591	US$892.8	0%	no data
0.015%	A. Weil	1,112	US$623.8	0%	no data
0.013%	BlackRock, Inc.	975	US$546.8	0%	no data
0.0046%	Advisory Services Network, LLC	347	US$194.5	0%	no data
0.0027%	David Humphrey	208	US$116.6	43.5%	no data
0.00032%	Wells Fargo & Company, Private Banking and Investment Banking Arm	24	US$13.6	14.3%	no data
0.00026%	Plante Moran Financial Advisors, LLC	20	US$11.1	0%	no data
0.00004%	UBS Asset Management AG	3	US$1.7	-98%	no data